Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Ранг среди акций #31257
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Цена акции
$0.39
Рыночная капитализация
$13.79M
Изменение (1 день)
-13.53%
Изменение (1 год)
-68.80%
Страна
IL
Торговля NeuroSense Therapeutics Ltd. (NRSN)

Категория

Коэффициент P/B для NeuroSense Therapeutics Ltd. (NRSN)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций NeuroSense Therapeutics Ltd., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для NeuroSense Therapeutics Ltd. с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH
3.4612 -
BE